Helicobacter pylori

H. Pylori and Gastric Cancer
H. Pylori and Gastric Cancer 1024 1024 ALLIANCE™ Laboratories

H. Pylori and its link to Gastric Cancer Discovery

In 2005, Australian scientists Dr. Barry Marshall and Dr. Robin Warren were awarded the Nobel Prize in Medicine for their groundbreaking discovery of Helicobacter pylori (H. pylori) bacterium and its role in causing chronic gastritis and gastric ulcers.  Their discovery also underscored the potential link between chronic H. pylori infection and the increased risk of developing gastric cancer, highlighting the importance of addressing this infection to prevent more severe gastrointestinal diseases. This was a pivotal moment in medical science, demonstrating that H. pylori infection is the main cause of these conditions, fundamentally shifting how these diseases are treated.

What is H. Pylori?

Pylori is a gram-negative bacterium which causes chronic gastritis and plays important roles in peptic ulcer disease, gastric carcinoma, and gastric lymphoma. H. pylori has been found in the stomachs of humans in all parts of the world. In developing countries, 70 to 90% of the population carries H. pylori. In developed countries, the prevalence of infection is lower, however H. pylori remains to be the leading cause of stomach cancer. 

How does H. Pylori cause Gastritis and Gastric cancer?

Pylori is usually transmitted in childhood and persists for life if untreated. It colonizes the stomach, where it is able to survive and thrive. This is made possible by unique properties and adaptations to survival within highly acidic environments of the human stomach. Its shape plays a crucial role in its survival; H. pylori is helix-shaped, which enables it to penetrate the stomach’s mucous lining and attach to the epithelial cells beneath. This not only shields the bacterium from acidic conditions but also places it close to the less acidic mucus layer near the stomach lining, providing a more hospitable environment. H. pylori has also got several mechanisms to neutralize the acid around it, the most notable being its ability to produce enzyme urease. It catalyzes the conversion of urea (naturally present in the stomach) to carbon dioxide and ammonia. The ammonia then reacts with the gastric acid to form ammonium, which helps buffer the stomach’s pH around the bacterium. This localized increase in pH protects H. pylori from the otherwise lethal acidity of the stomach, allowing it to colonize this challenging environment effectively. These adaptations not only aid its survival but also contribute to the pathogenic effects leading to gastric ulcers and increased risks of developing gastric cancer.

H. Pylori Symptoms

H. pylori causes persistent inflammation of the gastric mucosa, leading to frequent damage of the epithelial cells lining the stomach. This means that the cells need to be constantly regenerating, which increases the risk of mutations during DNA replication. This is exacerbated due to H. pylori’s ability to disrupt cellular pathways by activating oncogenes and inactivating tumor suppressor genes. H. pylori produces an oncoprotein CagA (cytotoxic associated gene A), which disrupts the Wnt pathway, which is crucial in cell regeneration, in gastric epithelial cells, compromising the proliferation and differentiation of gastric stem and progenitor cells and promoting carcinogenesis.  This results in uncontrolled cell growth and accumulation of genetic abnormalities. 

Diagnosing H. Pylori Infection

A variety of tests to diagnose H. pylori infection are now available. Histological examination of gastric tissue, culture, rapid urease testing, DNA probes, and PCR analysis, when used to test gastric tissue, all require endoscopy. During endoscopic biopsy,  tissue samples are removed from the stomach lining to be tested for presence of H. pylori. It is highly accurate and can also assess the degree of stomach damage and the presence of cancerous changes.

Treating H. Pylori Infection

H. pylori treatment consists of a strong acid suppressant in various combinations with antibiotics and/or bismuth. The dramatic increase in resistance to key antibiotics used in H. pylori eradication demands antibiotic susceptibility testing, surveillance of resistance and antibiotic stewardship. The standard treatment involves a combination of two or three antibiotics (e.g., clarithromycin, amoxicillin, metronidazole) to overcome bacterial resistance, along with a proton pump inhibitor (PPI) to reduce stomach acid. This helps improve the antibiotics’ effectiveness and promotes healing of the stomach lining. Treatment typically lasts for two weeks. After completion, testing may be repeated to confirm that the infection has been successfully eradicated. However, in cases where complications such as ulcers have developed, additional treatments, including increased acid suppression or surgery, might be necessary.

Understanding the impact of Helicobacter pylori (H. pylori) infection is crucial due to its association with various serious stomach diseases. Increased awareness about how this bacterium is transmitted and its potential health consequences can lead to early detection and more effective management of related diseases.

If you or someone you know experiences persistent stomach discomfort, such as pain, bloating, nausea, or unexplained weight loss, it’s important to consult a healthcare provider. Early diagnosis and treatment of H. pylori infection can significantly reduce the risk of developing more severe gastrointestinal conditions. Don’t hesitate to seek medical advice to ensure your stomach health is maintained, and encourage others to do the same.

 

Gastritis Diagnosis and Treatment; Gastritis Laboratory Testing

Gastritis: Insights From Alliance
Gastritis: Insights From Alliance 1024 1024 ALLIANCE™ Laboratories

Gastritis encompasses a wide range of conditions characterized by the inflammation of the stomach lining. Normally, this lining produces mucus that protects our stomachs from the stomach acid and digestive enzymes. In case of gastritis it fails to complete its function. As a prevalent digestive issue, which affects millions worldwide, underscoring the importance of awareness and timely medical intervention.

At ALLIANCE™ Laboratories, we harness advanced diagnostic techniques to pinpoint the specific causes of gastritis. This enables targeted treatments that enhance patient outcomes. Our commitment to precision places us at the forefront of gastroenterological care. Both patients and healthcare providers receive reliable and actionable health insights. Read this article to find out more about what gastritis is, its causes, and how our specialized diagnostic services play a pivotal role in the effective management of this condition.

Gastritis Diagnosis and Treatment

What is Gastritis?

Gastritis is an inflammation of the stomach lining that can occur suddenly (acute gastritis) or gradually (chronic gastritis). Its symptoms range from mild indigestion and nausea to severe abdominal pain and vomiting. Chronic gastritis usually slowly develops over time and often remains undetected until symptoms become pronounced. This inflammation can lead to erosion of the stomach lining, causing ulcers and increasing the risk of stomach cancer. 

Causes of Gastritis:

The causes of gastritis vary, ranging from infections to lifestyle factors. The most common cause is infection with Helicobacter pylori (H. pylori), a bacterium that colonizes the stomach mucosa. Other significant contributors include long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) and excessive alcohol consumption, both of which can weaken the stomach’s protective lining and increase acidity, leading to inflammation. Accidental ingestion of bleach and other toxic chemicals (eg: Wisteria plant) can also cause ulcers. Additionally, stress, autoimmune disorders where the body attacks its own stomach lining, and bile reflux disease can also be a cause. Less frequently, it can result from other medical conditions, including viral infections, especially in people with weakened immune systems. Identifying the precise cause is essential, as it directs the treatment strategy and involves a detailed diagnostic process, which can vary significantly from one patient to another.

Diagnosis of gastritis:

At ALLIANCE™, we perform the histological exam, which involves taking a biopsy sample of the stomach’s tissue that has been fixed in the formalin solution and staining it with different dyes to identify specific patterns of inflammation, cellular damage, or abnormal growth that are indicative of various types of gastritis. 

We employ a specialized Immunohistochemistry (IHC) staining technique that is particularly useful in detecting H. pylori. This technique uses antibodies that specifically bind to antigens produced by H. pylori, which are then visualized using a dye or a marker, providing clear evidence of infection. 

We present the results of our examination in a detailed full-color report.  

Treatment 

Treatment for gastritis depends largely on the underlying cause, but generally aims to reduce stomach acid and heal the stomach lining. For gastritis associated with H. pylori infection, a combination of antibiotics to eradicate the bacteria and proton pump inhibitors (PPIs) to reduce acid production is commonly prescribed. In cases where NSAIDs are the culprits, discontinuing their use along with PPI therapy can significantly alleviate symptoms. For alcohol-related gastritis, abstaining from alcohol and possibly receiving PPI or H2 antagonist treatments can provide relief. Additionally, antacids neutralize stomach acid and reduce immediate discomfort. Dietary modifications, such as avoiding spicy and acidic foods, can also help manage symptoms. In all cases, ongoing monitoring by healthcare providers ensures that we can base the treatments on patient response and laboratory results.

Prevention Tips 

Preventing gastritis starts with lifestyle choices. Reducing the intake of irritants such as alcohol, spicy foods, and NSAIDs can prevent the onset of its symptoms. Maintaining a balanced diet and managing stress through relaxation techniques or therapy can also help. For those at risk of H. pylori infection, good hygiene practices such as washing hands thoroughly and drinking clean water are essential. Regular check-ups and discussing any digestive discomfort with a healthcare provider early can lead to timely interventions, preventing complications associated with gastritis.

Conclusion 

Understanding and managing gastritis effectively requires a clear grasp of its symptoms, causes, and treatment options. At ALLIANCE™, our state-of-the-art laboratory equipment plays a crucial role in accurately diagnosing gastritis. We enable personalized treatment plans that lead to better patient outcomes. By adopting preventative measures and seeking timely medical advice, individuals can significantly reduce their risk of developing gastritis. For healthcare providers, partnering with a specialized laboratory like ours ensures that diagnoses are precise and treatments are effectively tailored to each patient’s needs. Together, we can tackle the challenges of gastritis and enhance the quality of life for those affected.

Enter your
text here